文献速递先天性心脏病外科

先天性左向右分流相关肺血管疾病的管理:单中心经验

Management of pulmonary vascular disease associated with congenital left-to-right shunts: A single-center experience.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-05-18

该回顾性单中心研究描述了2015年9月至2021年9月期间51例18岁以下左向右分流合并肺动脉高压(定义肺血管阻力指数≥4 Wood单位·m²)且无艾森曼格生理的患儿,接受「先治疗」或「先修复」两种管理策略的病程与结局。先治疗组33例中27例(82%)完成分流关闭,先修复组18例中12例(67%)接受肺动脉高压治疗;两组死亡率分别为6%和11%,分流关闭后中位随访2年肺血管阻力指数无显著变化(P=0.77)。

要点

  • 先治疗组82%完成分流关闭,6例(18%)对肺动脉高压治疗无反应未关闭分流。
  • 先修复组67%接受肺动脉高压治疗,33%未接受。
  • 分流关闭后中位随访2年肺血管阻力指数无显著变化(P=0.77)。

核心结论

  • 在左向右分流合并肺动脉高压的儿童中,修复前接受肺动脉高压靶向治疗似乎不会危及受试者,并可能有一定获益。
  • 分流关闭前对肺动脉高压靶向治疗的反应在关闭后持续2至3年,为这些患者的长期管理提供了有价值的见解。

研究设计与样本

  • 回顾性单中心研究,纳入2015年9月至2021年9月期间18岁以下左向右分流合并肺动脉高压(肺血管阻力指数≥4 Wood单位·m²)且无艾森曼格生理的患儿。
  • 共评估768例拟行左向右分流关闭的患者,其中51例(6.8%)合并肺动脉高压,中位年龄1.1(0.37-5)岁,中位肺血管阻力指数6(5.2-8.7)Wood单位·m²。
  • 按管理策略分为「先治疗」组(n=33,65%)和「先修复」组(n=18,35%)。

主要发现

  • 「先治疗」组33例中27例(82%)完成左向右分流关闭,6例(18%)对肺动脉高压治疗无反应且未行分流关闭。
  • 「先修复」组18例中12例(67%)接受肺动脉高压治疗,6例(33%)未接受。
  • 「先治疗」组死亡率为6%,「先修复」组为11%,随访时间分别为3.4年和2.5年。
  • 分流关闭后中位随访2年,肺血管阻力指数无显著变化(P=0.77)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to describe the course and outcomes of children under 18 years of age, with left-to-right shunts and pulmonary arterial hypertension undergoing 1 of 2 management approaches: pulmonary arterial hypertension treatment before left-to-right shunt repair (Treat First) and left-to-right shunt repair first with or without subsequent pulmonary arterial hypertension treatment (Repair First). METHODS: We performed a retrospective single-center study, conducted from September 2015 to September 2021, of children with left-to-right shunts and pulmonary arterial hypertension (defined as indexed pulmonary vascular resistance ≥ 4 Wood units [WU]∗m2) but without Eisenmenger physiology. Patient characteristics, longitudinal hemodynamics data, pulmonary arterial hypertension management, left-to-right shunt repair, and outcomes were reviewed. RESULTS: Of 768 patients evaluated for left-to-right shunt closure, 51 (6.8%) had left-to-right shunts associated with pulmonary arterial hypertension (median age 1.1 [0.37-5] years, median indexed pulmonary vascular resistance 6 [5.2-8.7] WU∗m2). In the "Treat First" group (n = 33, 65%), 27 patients (82%) underwent left-to-right shunt closure and 6 patients (18%) did not respond to pulmonary arterial hypertension therapy and did not undergo left-to-right shunt closure. In the "Repair First" group (n = 18, 35%), 12 patients (67%) received pulmonary arterial hypertension therapy and 6 patients (33%) did not. Mortality rates were 6% in the "Treat First" group and 11% in "Repair First" group with follow-ups of 3.4 and 2.5 years, respectively. After left-to-right shunt closure, there was no significant change in indexed pulmonary vascular resistance over a median follow-up of 2 years after surgery (P = .77). CONCLUSIONS: In children with left-to-right shunts and associated pulmonary arterial hypertension, treatment with pulmonary arterial hypertension-targeted therapy before defect repair does not appear to endanger the subjects and may have some benefit. The response to pulmonary arterial hypertension-targeted therapy before shunt closure persists 2 to 3 years postclosure, providing valuable insights into the long-term management of these patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nawaytou H, Lakkaraju R, Stevens L, et al. Management of pulmonary vascular disease associated with congenital left-to-right shunts: A single-center experience. J Thorac Cardiovasc Surg. 2024. PMID: 38763305. doi:10.1016/j.jtcvs.2024.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。